How Pharma Companies Can Mitigate The Impact Of US Tariffs On The Supply Chain

 
• By Ewan Townsend
  
US tariffs could be disruptive for companies buying and selling active pharmaceutical ingredients if they come into force

More from Distribution/Supply Chain

More from Legislation